Jump to content
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy
  • Project pages
    • MDR & IVDR
    • Innovation & Startups

BIOPRO BW Logo

Main navigation

  • Start page Start page
  • About us

    About us

    Close Close
    • Team
      • Our authors
    • History and achievements
    • Supervisory Board
    • Career
    • Contact / Travel information
  • Activities

    Activities

    Close Close
    • Start-up support
    • Cooperation initiatives
    • Anlaufstelle Regulatorik Gesundheitswirtschaft BW
  • Projects

    Projects

    Close Close
    • Current projects
      • Forum Health Region Baden-Württemberg
      • Advanced Imaging Utilization by Digital Data Application in Baden-Württemberg (PC3-AIDA)
      • Alliance for sustainable medical technology
      • The Phytopharmaceuticals and Valuable Plant Ingredients initiative
      • PRECISEU - PeRsonalised medicine Empowerment Connecting Innovation ecoSystems across EUrope
      • HACK-IT-NET - enabling an alpine region Health And Care Knowledge and Innovation Transfer NETwork
    • General Projects
      • EXI Start-Up Voucher
      • LinkHealth@BW
    • Completed projects
      • MDR & IVDR Fast-Track Support BW
      • Photon-Counting (PC)-CT Consortium
      • Health Data Scenarios
      • Baden-Württemberg-Center for Academic Drug Discovery
      • Post-Brexit
      • MDR & IVDR Competence Centre BW (MIK)
  • Services

    Services

    Close Close
    • Funding
    • Research institutions
    • Healthcare industry database
    • Job market
    • Newsletter
    • Stay in touch with us!
  • Information

    Information

    Close Close
    • Press releases & contact
    • Publications
  • Events

    Events

    Close Close
  • de
  • en
Show menu Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Press release - 09/12/2024

    Brain tumour cells rapidly integrate into brain-wide neuronal circuits

    Researchers at the Medical Faculty of Heidelberg University and the Heidelberg University Hospital have used modified rabies viruses to label glioblastoma tumour cells and their direct cell contacts in the mouse brain. The new method showed that the tumour cells are connected to different types of nerve cells throughout the entire brain at a very early stage of the disease.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/brain-tumour-cells-rapidly-integrate-brain-wide-neuronal-circuits
  • Event - 24/05/2025 - 25/05/2025

    Sahlgrenska Global Health Hackathon

    Göttingen, Registration deadline: 24/12/2024, Hackathon
    https://www.gesundheitsindustrie-bw.de/en/event/sahlgrenska-global-health-hackathon
  • Dossier: Innovative animal-free research in Baden-Württemberg - 05/12/2024 A watercolour painting depicts a rhesus monkey wearing a surgical mask sitting at a laboratory bench, with two white mice looking up at him. He sticks his thumb up in the air. In the foreground is a petri dish with a bean-shaped organoid. There are microscopes in the background and a poster on the wall with the words ‘No more Animal Testing’.

    Mini-organs and multi-organ chips - where lab mice may soon retire

    Farewell to animal testing? Life sciences researchers in BW are pioneering innovative methods to replace animal experiments, reduce the number of animals used and refine the procedures and conditions under which animals are kept. These are the guiding principles of the 3Rs principle. Developing cutting-edge models and establishing a robust 3R network, not only shapes the future of research but also improves the quality of scientific outcomes.

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/mini-organs-and-multi-organ-chips-where-lab-mice-may-soon-retire
  • Press release - 04/12/2024

    Joint research in key technologies: NMI and KIT sign cooperation agreement

    The NMI Natural and Medical Sciences Institute and the Karlsruhe Institute of Technology (KIT) have signed a groundbreaking cooperation agreement. This partnership combines the expertise of both institutions in the fields of production and characterization of materials for biological systems and energy storage as well as the application of statistical methods in medicine.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/joint-research-key-technologies-nmi-and-kit-sign-cooperation-agreement
  • NMI spin-off develops theranostics - 02/12/2024 Before immunotherapy weak ICE-T signals in the tumour in blue and green, after immunotherapy strong signals in red and pink.

    immuneAdvice develops diagnostics to predict the efficacy of immunotherapies

    Certain types of cancer are already being effectively treated using immunotherapies, though success rates can vary significantly between patients. Researchers from the Natural and Medical Sciences Institute (NMI) in Reutlingen, along with colleagues at the University of Tübingen, are working on a diagnostic approach to accompany therapy, which would rapidly assess whether the treatment is effective or requires adjustment.

    https://www.gesundheitsindustrie-bw.de/en/article/news/immuneadvice-develops-diagnostics-predict-efficacy-immunotherapies
  • Press release - 28/11/2024

    Molecular biology: New interdisciplinary Research Training Group investigates cellular regulation

    Cell division, cell differentiation, cell repair and cell death play fundamental roles in the human organism, its development, health and reproduction. Cellular transformation processes are governed by two regulatory mechanisms: chromatin modifications and cell signaling networks. The EpiSignal Research Training Group sheds light on the hitherto little-researched interplay between these two complex systems.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/molecular-biology-new-interdisciplinary-research-training-group-investigates-cellular-regulation
  • Vicinity Bio: Optimisation of cancer diagnostics - 27/11/2024 Das Bild zeigt eine mikroskopische Aufnahme eines Gewebes. Die Aufnahme ist bunt und unterschiedliche Zelltypen lassen sich deutlich erkennen.

    Comprehensive histological diagnostics through high-dimensional imaging and artificial intelligence

    Microscopic examination of tissue samples is essential, particularly in tumour diagnostics. The Tübingen-based company Vicinity Bio leverages cutting-edge imaging technologies combined with machine learning to generate comprehensive datasets of individual cells from tissue sections. This approach not only helps identify more targeted therapies but also enhances our understanding of cellular functions and processes within tissues and tumours.

    https://www.gesundheitsindustrie-bw.de/en/article/news/Comprehensive-histological-diagnostics-through-high-dimensional-imaging-and-artificial-intelligence
  • Press release - 26/11/2024

    Collaborative research centres on kidney and brain prolonged

    On 25 November, the German Research Foundation (DFG) announced the continued funding of two existing Collaborative Research Centres (CRC) at the University of Freiburg’s Faculty of Medicine. In CRC 1453 Nephrogenetics (NephGen), doctors and researchers are using genetic information to search for mechanisms underlying kidney diseases.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/collaborative-research-centres-kidney-and-brain-prolonged
  • Press release - 25/11/2024

    Chromosomal chaos promotes therapy resistance in leukemia cells and opens up new treatment approaches

    Chromosomal instability plays a role in the progression of cancer: it shapes the properties of tumor cells and drives the development of therapy resistance. Scientists from the German Cancer Research Center (DKFZ), the Heidelberg Stem Cell Institute HI-STEM* and the European Molecular Biology Laboratory (EMBL) used state-of-the-art single-cell analysis methods to analyze the cellular heterogeneity of a specific form of acute myeloid leukemia.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/chromosomal-chaos-promotes-therapy-resistance-leukemia-cells-and-opens-new-treatment-approaches
  • Press release - 20/11/2024

    Millions in federal funding: customized 3D printing for patients in oral and maxillofacial surgery

    The German Federal Ministry of Education and Research (BMBF) is currently funding a project at the Department of Oral and Maxillofacial Surgery at Heidelberg University Hospital with around 1.2 million euros. The aim is to use 3D printing technology to produce individualized implants directly in the clinic, thus enabling faster, more efficient and more precise patient-specific care. To this end, the UKHD is working with an industrial partner.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/millions-federal-funding-customized-3d-printing-patients-oral-and-maxillofacial-surgery
  • Press release - 20/11/2024

    Research team develops novel biomimetic speaking valve technology

    The challenge: if conventional speaking valves are used improperly, dangerous overpressure can occur, which can cause serious complications and even death. In a collaboration at the University of Freiburg, researchers developed a speaking valve with an integrated pressure release valve and an acoustic warning signal, inspired by the trapping mechanism of the carnivorous bladderwort plant Utricularia vulgaris.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/forschungsteam-entwickelt-neuartige-biomimetische-sprechventil-technologie
  • Press release - 20/11/2024

    New bioengineering approaches for the automated production of complex organoids

    The reproducible and precise production of complex organoid models to simulate human organ malfunctions is the focus of an interdisciplinary research project at Heidelberg University. A research team from the life and engineering sciences is looking to combine the engineering of molecular systems with machine learning and automated production methods.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/neue-ansaetze-des-bio-engineering-fuer-die-automatisierte-herstellung-komplexer-organoide
  • Greener NHS - 18/11/2024 Teaser image intended to represent the National Health Service in the UK. It shows the upper body of a doctor, with a hospital corridor in the background. To the right of the doctor is the slightly transparent outline of the British flag in the shape of Great Britain.

    National Health Service working towards climate neutrality

    The National Health Service (NHS) in the United Kingdom and Northern Ireland is taking steps to become more environmentally sustainable. The NHS has committed to the ambitious goal of achieving net zero carbon emissions by 2040, aiming to significantly reduce its climate impact in the coming years.

    https://www.gesundheitsindustrie-bw.de/en/article/news/national-health-service-working-towards-climate-neutrality
  • Event - 28/11/2024

    Venture Capital Meet & Greet - Catalpa Ventures

    Online, Webinar
    https://www.gesundheitsindustrie-bw.de/en/event/venture-capital-meet-und-greet-catalpa-ventures
  • Press release - 15/11/2024

    Selenium proteins as a possible new target for cancer research

    An important enzyme helps the body produce selenium proteins – this discovery could open up new strategies for treating cancer in children. This has been published by scientists from the University of Würzburg, the University Sao Paolo, the German Cancer Research Center (DKFZ) and the Heidelberg Stem Cell Institute HI-STEM*.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/selenium-proteins-possible-new-target-cancer-research
  • Press release - 15/11/2024

    Patient association raises 10,000 euros for work on PURA syndrome - Donation for research into rare neuronal developmental disorder at Ulm University

    PURA syndrome is a rare developmental disorder of the brain for which there is currently no cure. The patient association PURA Syndrome Germany was founded last year. Since then, the affected families have been collecting donations with great dedication – and have decided to donate the majority of this money to research into the syndrome at Ulm University.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/patient-association-raises-10000-euros-work-pura-syndrome-donation-research-rare-neuronal-developmental-disorder-ulm-university
  • Press release - 14/11/2024

    Novel method for fighting tumors

    Making existing cancer therapy more efficient while significantly reducing the side effects on healthy tissue - this is the aim of a project at Aalen University. It is being funded with one million euros from the Carl Zeiss Foundation. The biophysicist and his team are developing innovative nanoparticles made of gold. The particles use radiotherapy and chemotherapy simultaneously and kill the cancer cells in a targeted manner.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/novel-method-for-fighting-tumors
  • Advancing quantum technology into real-world applications - 06/11/2024 Measurement setup with a quantum sensor.

    QSens: BMBF future cluster brings quantum sensors of the future into medicine

    The BMBF-funded future cluster ‘QSens – Quantum Sensors of the Future’ is developing ultra-sensitive sensors that could open up new options in medicine, enabling faster drug research, more accurate diagnostics and improved rehabilitation. The universities of Stuttgart and Ulm are actively working with 17 industry partners to put these cutting-edge innovations to immediate practical use.

    https://www.gesundheitsindustrie-bw.de/en/article/news/qsens-bmbf-future-cluster-brings-quantum-sensors-future-medicine
  • Press release - 05/11/2024

    How biomedical innovation improves preclinical research

    3D tumor models, simulations of drug responses or plant stems used for testing heart stents: the 3R-BioMedicUS center at the University of Stuttgart is developing innovative biomedical approaches to improve preclinical studies, to be seen in the new video.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-biomedical-innovation-improves-preclinical-research
  • Press release - 05/11/2024

    Heidelberg scientist receives highly endowed EC synergy grant

    Heidelberg scientist Dr Venera Weinhardt has received an ERC Synergy Grant for a pioneering biomedical research project. The European Research Council (ERC) is granting this funding to advance soft X-ray microscopy. This imaging technique along with other innovations will be used to investigate the hepatitis E virus.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/heidelberg-scientist-receives-highly-endowed-ec-synergy-grant
  • Press release - 30/10/2024

    Diabetes switch in DNA: Non-coding region in the genome influences ONECUT1 gene

    They are underestimated genetic control elements: it is known that changes in the genome can trigger diabetes. But now researchers at the University Hospital Ulm and the INSERM Cochin Institute in Paris have shown that a previously under-researched region of the genome also plays a crucial role in the development of this disease.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/diabetes-switch-dna-non-coding-region-genome-influences-onecut1-gene
  • NMI project WOUNDSENS - 23/10/2024 electrospinning_WoundSens.jpg

    Wound monitoring using sensory nanofibres

    Monitoring the condition of chronic, non-healing wounds requires wound dressings to be changed at short, regular intervals. In the EU-funded WOUNDSENS project, researchers at the NMI in Reutlingen are using electrospinning to produce novel types of wound dressings. These consist of biosensory fibres that send information about the condition of the wound to the outside, thereby improving inflammation detection.

    https://www.gesundheitsindustrie-bw.de/en/article/news/wound-monitoring-using-sensory-nanofibres
  • Press release - 16/10/2024

    Sensitive Arm Prostheses

    A quantum sensor that can register nerve impulses without contact opens up new possibilities in prosthetics. Researchers at Fraunhofer IPA are developing together with the industrial partner Q.ANT the prototype of one Prosthetic arm that is controlled by neural commands like healthy limbs.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/sensitive-arm-prostheses
  • Sustainable medical technology - 10/10/2024 Various plastic medical items such as gloves, tablet blisters, containers, syringes and a blood pressure monitor are arranged on a green background.

    Rethinking plastics in medical technology

    Good healthcare relies heavily on medical products made from plastic. However, the widespread use of synthetic materials, particularly disposable items, creates vast amounts of waste, depletes resources and leads to a substantial carbon footprint. To create more environmentally friendly plastic products in the future, substantial changes to production processes are essential.

    https://www.gesundheitsindustrie-bw.de/en/article/news/rethinking-plastics-medical-technology
  • Press release - 09/10/2024

    Language model "UroBot“ surpasses the accuracy of experienced urologists

    Scientists at the German Cancer Research Center (DKFZ), together with doctors from the Urological Clinic of the Mannheim University Hospital, have developed and successfully tested a chatbot based on artificial intelligence. "UroBot" was able to answer questions from the urology specialist examination with a high degree of accuracy, surpassing both other language models and the accuracy of experienced urologists.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/language-model-urobot-surpasses-accuracy-experienced-urologists

Page 5 / 48

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 48
  • eine Seite zurück
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • About us
    • Team
    • History and achievements
    • Supervisory Board
    • Career
    • Contact / Travel information
  • Activities
    • Start-up support
    • Cooperation initiatives
    • Anlaufstelle Regulatorik Gesundheitswirtschaft BW
  • Projects
    • Current projects
    • General Projects
    • Completed projects
  • Services
    • Funding
    • Research institutions
    • Healthcare industry database
    • Job market
    • Newsletter
    • Stay in touch with us!
  • Information
    • Press releases & contact
    • Publications
  • Events
  • Project pages
    • MDR & IVDR
    • Innovation & Startups
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Newsletter abonnieren

Social Media

  • Xing Xing
  • Twitter visit Twitter
  • LinkedIn visit LinkedIn
  • Rss visit RSS
  • Privacy statement
  • Accessability Declaration
  • Legal notice
  • Sitemap
  • Contact
© 2025
Website address: https://www.bio-pro.de/en/search